How Metzger was paid
$7.1M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Michael A. MetzgerChief Executive Officer | $754,300 | $2,021,965 | $3,454,360 | $848,588 | $10,000 | $7,089,213 |
| Keith A. GoldanChief Financial Officer | $516,900 | $569,609 | $1,048,645 | $325,648 | $10,000 | $2,470,802 |
| Luke J. AlbrechtGeneral Counsel and Secretary | $496,900 | $540,309 | $949,000 | $335,408 | $10,000 | $2,331,617 |
| Nick Botwood, M.B.B.S.Head of Research & Development, Chief Medical Officer | $345,682 | $285,792 | $1,913,500 | $334,125 | — | $2,879,099 |
| Steve ClosterChief Commercial Officer | $485,300 | $496,359 | $806,650 | $327,578 | $10,000 | $2,125,887 |
What changed and why
- $7.1MCEO total compensation decreased to $7,089,213 in 2025 from $7,707,176 in 2024.
- $754KChief Executive Officer base salary increased to $754,300 for fiscal year 2025.
- Annual performance-based cash bonuses were awarded based on company and individual goal achievements.
- Equity-based incentive awards included stock options and performance-based restricted stock units.
- The ratio of annual total compensation of the median employee to the CEO was 19 to 1.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.